Prof. Andrew Wardley is a consultant medical oncologist and expert in breast cancer treatment and research. After graduating from The University of Manchester in 1989, he completed his general medical training in 1993, and specialist medical oncology training, including an MSc and research doctorate, in 2000. In 2001, he took up the post of consultant medical oncologist for breast cancer at The Christie.

Prof. Wardley is known internationally for his research into breast cancer, which is widely published. His focus is on identifying resistance pathways in advanced breast cancer and introducing new treatments.

Prof. Wardley is dedicated to advancing the field of breast cancer treatment through both clinical practice and research. He is particularly interested in the mechanisms of resistance in advanced breast cancer and the development of innovative therapies to overcome these challenges.

Prof. Wardley specialises in the treatment of breast cancer, employing a range of procedures including chemotherapy and genetic testing. He is also involved in cancer prevention and screening programmes, aiming to detect and treat cancer at the earliest possible stage.

Since his appointment in 2001, Prof. Wardley has been a pivotal figure at The Christie, contributing significantly to both patient care and the broader medical community through his research and clinical expertise.